129 related articles for article (PubMed ID: 15656335)
1. Differential tumor microenvironment in human ovarian cystic tumors.
Tavares Murta BM; Cunha Fde Q; Miranda R; Adad SJ; Murta EF
Tumori; 2004; 90(5):491-7. PubMed ID: 15656335
[TBL] [Abstract][Full Text] [Related]
2. Is differentiation of benign and malignant cystic adnexal masses possible by evaluation of cysts fluids with respect to color, cytology, steroid hormones, and tumor markers?
Gaetje R; Popp LW
Acta Obstet Gynecol Scand; 1994 Jul; 73(6):502-7. PubMed ID: 8042465
[TBL] [Abstract][Full Text] [Related]
3. [CA 125, CA 19.9, MCA, CEA, 17 beta-estradiol and progesterone in functional and benign cysts and carcinoma of the ovary].
Caione C; Minelli L; Angiolillo M
Minerva Ginecol; 1994 Jun; 46(6):321-35. PubMed ID: 7936384
[TBL] [Abstract][Full Text] [Related]
4. Intracystic evaluation of tumor markers in benign and malignant ovarian pathology.
Cherchi PL; Capobianco G; Ambrosini G; Fadda GM; Piga MD; Ruiu G; Fattorini F; Dessole S
Eur J Gynaecol Oncol; 2002; 23(2):163-5. PubMed ID: 12013118
[TBL] [Abstract][Full Text] [Related]
5. Estradiol, gonadotropins, and tumor markers in ovarian cyst fluid.
Reimer T; Gerber B; Kunkel S; Luettich K
Acta Obstet Gynecol Scand; 1997 May; 76(5):478-83. PubMed ID: 9197453
[TBL] [Abstract][Full Text] [Related]
6. Ovarian mucinous cystadenocarcinoma with yolk sac tumor in a 71-year-old woman.
Arai T; Kitayama Y; Koda K
Int J Gynecol Pathol; 1999 Jul; 18(3):277-80. PubMed ID: 12090598
[TBL] [Abstract][Full Text] [Related]
7. CA 125, CA 15.3, CA 27.29, CEA, beta-hCG and alpha-fetoprotein levels in cyst fluid of breast macrocysts.
Martínez L; Castilla JA; Blanco N; Perán F; Herruzo A
Int J Gynaecol Obstet; 1995 Feb; 48(2):187-92. PubMed ID: 7540567
[TBL] [Abstract][Full Text] [Related]
8. The chemotactic cytokine interleukin-8--a cyst fluid marker for malignant epithelial ovarian cancer?
Ivarsson K; Runesson E; Sundfeldt K; Haeger M; Hedin L; Janson PO; Brännström M
Gynecol Oncol; 1998 Dec; 71(3):420-3. PubMed ID: 9887242
[TBL] [Abstract][Full Text] [Related]
9. Peritoneal fluid cytokines and the differential diagnosis of benign and malignant ovarian tumors and residual/recurrent disease examination.
Chechlinska M; Kaminska J; Markowska J; Kramar A; Steffen J
Int J Biol Markers; 2007; 22(3):172-80. PubMed ID: 17922459
[TBL] [Abstract][Full Text] [Related]
10. Cyst fluid analysis obtained by EUS-guided FNA in the evaluation of discrete cystic neoplasms of the pancreas: a prospective single-center experience.
Linder JD; Geenen JE; Catalano MF
Gastrointest Endosc; 2006 Nov; 64(5):697-702. PubMed ID: 17055859
[TBL] [Abstract][Full Text] [Related]
11. Cyst fluid analysis in the differential diagnosis of pancreatic cysts. A comparison of pseudocysts, serous cystadenomas, mucinous cystic neoplasms, and mucinous cystadenocarcinoma.
Lewandrowski KB; Southern JF; Pins MR; Compton CC; Warshaw AL
Ann Surg; 1993 Jan; 217(1):41-7. PubMed ID: 8424699
[TBL] [Abstract][Full Text] [Related]
12. [Differential diagnosis of cystic ovarian tumors by determination of estradiol in cystic aspirate].
Ammann M; Hänggi W; Baumann U; Keller PJ
Geburtshilfe Frauenheilkd; 1991 Jun; 51(6):481-3. PubMed ID: 1889731
[TBL] [Abstract][Full Text] [Related]
13. Comparison of biochemical markers between benign and malignant ovarian cysts.
Knight JA; Wu JT; Miya T; Knight DP
Clin Physiol Biochem; 1986; 4(2):130-5. PubMed ID: 3516514
[TBL] [Abstract][Full Text] [Related]
14. Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions.
Porcel JM; Vives M; Esquerda A; Salud A; Pérez B; Rodríguez-Panadero F
Chest; 2004 Dec; 126(6):1757-63. PubMed ID: 15596670
[TBL] [Abstract][Full Text] [Related]
15. Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecological cancers.
Dolscheid-Pommerich RC; Keyver-Paik M; Hecking T; Kuhn W; Hartmann G; Stoffel-Wagner B; Holdenrieder S
Tumour Biol; 2017 Oct; 39(10):1010428317730246. PubMed ID: 29034816
[TBL] [Abstract][Full Text] [Related]
16. Differential diagnosis of peri- and postmenopausal ovarian cysts.
Reimer T; Gerber B; Müller H; Jeschke U; Krause A; Friese K
Maturitas; 1999 Jan; 31(2):123-32. PubMed ID: 10227005
[TBL] [Abstract][Full Text] [Related]
17. Aspiration cytology of neoplastic and non-neoplastic ovarian cysts: is it accurate?
Ganjei P; Dickinson B; Harrison T; Nassiri M; Lu Y
Int J Gynecol Pathol; 1996 Apr; 15(2):94-101. PubMed ID: 8786211
[TBL] [Abstract][Full Text] [Related]
18. CA 125 and vascular endothelial growth factor in the differential diagnosis of epithelial ovarian tumors.
Candido Dos Reis F; Moreira de Andrade J; Bighetti S
Gynecol Obstet Invest; 2002; 54(3):132-6. PubMed ID: 12571433
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the sensitivity and specificity of serum level of prostasin, CA125, LDH, AFP, and hCG+β in epithelial ovarian cancer patients.
Bastani A; Asghary A; Heidari MH; Karimi-Busheri F
Eur J Gynaecol Oncol; 2017; 38(3):418-424. PubMed ID: 29693884
[TBL] [Abstract][Full Text] [Related]
20. Ovarian masses in children and adolescents - an analysis of 521 clinical cases.
Zhang M; Jiang W; Li G; Xu C
J Pediatr Adolesc Gynecol; 2014 Jun; 27(3):e73-7. PubMed ID: 24157281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]